drugset / Trial / NCT03480776
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
RandomizedParallel-groupTriple-blindPrevention
Summary
While ASA is not a cancer medication, research suggests that taking ASA reduces the probability of getting many types of cancer because of its anti-inflammatory action. Inflammation in the ovaries during ovulation is thought to contribute to the development of ovarian cancer, and, because ASA is an anti-inflammatory medication, it may help to prevent it.
Timeline
- Start
- 2018-07-24
- Primary completion
- 2026-06-30
- Completion
- 2026-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 81 mg | Oral |
| Comparator | Aspirin | Small molecule | 325 mg | Oral |